Pancreatic Cancer Research

Journal articleInt J Oncol2020

PHLPP2 is a novel biomarker and epigenetic target for the treatment of vitamin C in pancreatic cancer.

Journal
Int J Oncol
Published
25 February 2020
Citations
7
Type
Article

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Epigenetic dysregulations are closely associated with the development of pancreatic ductal adenocarcinoma (PDAC), which is one of the most aggressive malignancies and currently has limited treatment options. Vitamin C (VC), an epigenetic mediator, exerts antitumor effects on several types of cancer. … Excerpt only: this text is the publisher’s. Read it in full at the source.